Predictive value of direct bilirubin and total bile acid in lung adenocarcinoma patients treated with EGFR-TKIs
Abstract Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) have been the standard treatment for patients with sensitizing EGFR mutation. However, almost all patients eventually acquire resistance to EGFR-TKIs. Therefore, easily available parameters to estimate the outcome of...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | BMC Pulmonary Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12890-024-03367-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846158844112142336 |
|---|---|
| author | Yuting Li Bicheng Wang Shihong Fei You Qin |
| author_facet | Yuting Li Bicheng Wang Shihong Fei You Qin |
| author_sort | Yuting Li |
| collection | DOAJ |
| description | Abstract Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) have been the standard treatment for patients with sensitizing EGFR mutation. However, almost all patients eventually acquire resistance to EGFR-TKIs. Therefore, easily available parameters to estimate the outcome of lung adenocarcinoma patients treated with EGFR-TKIs are in urgent need. Lung adenocarcinoma patients harbored EGFR sensitive mutant and received EGFR-TKIs as first-line or second-line treatment were recruited in the study. X-tile software were utilized to determine the optimal cut-off value of Alkaline phosphatase (ALP), direct bilirubin (DB), total bile acid (TBA), and high-density lipoprotein-cholesterol (HDL-C). The prognostic value of ALP, DB, TBA, and HDL-C for Progression-free survival (PFS) in patients were evaluated by the Kaplan-Meier curve. We applied univariate and multivariate survival analysis to identify the independent predictor for PFS in patients with EGFR-mutant advanced lung adenocarcinoma and received EGFR-TKIs. A total of 131 lung adenocarcinoma patients with a median age of 58 years old were included in the final analysis. Patients with elevated level of DB and HDL-C showed a longer PFS, while high level of ALP and TBA indicated shorter PFS in response to EGFR-TKI treatment. The multivariate survival analyses revealed a significant association of prolonged PFS with increased DB, and decreased TBA. In conclusion, these findings suggest that DB and TBA were significant independent predictors of PFS in EGFR-TKI-treated patients with advanced lung adenocarcinoma. |
| format | Article |
| id | doaj-art-dbe1663ed75f48778633b41d79ff3c1a |
| institution | Kabale University |
| issn | 1471-2466 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Pulmonary Medicine |
| spelling | doaj-art-dbe1663ed75f48778633b41d79ff3c1a2024-11-24T12:09:00ZengBMCBMC Pulmonary Medicine1471-24662024-11-0124111110.1186/s12890-024-03367-1Predictive value of direct bilirubin and total bile acid in lung adenocarcinoma patients treated with EGFR-TKIsYuting Li0Bicheng Wang1Shihong Fei2You Qin3Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) have been the standard treatment for patients with sensitizing EGFR mutation. However, almost all patients eventually acquire resistance to EGFR-TKIs. Therefore, easily available parameters to estimate the outcome of lung adenocarcinoma patients treated with EGFR-TKIs are in urgent need. Lung adenocarcinoma patients harbored EGFR sensitive mutant and received EGFR-TKIs as first-line or second-line treatment were recruited in the study. X-tile software were utilized to determine the optimal cut-off value of Alkaline phosphatase (ALP), direct bilirubin (DB), total bile acid (TBA), and high-density lipoprotein-cholesterol (HDL-C). The prognostic value of ALP, DB, TBA, and HDL-C for Progression-free survival (PFS) in patients were evaluated by the Kaplan-Meier curve. We applied univariate and multivariate survival analysis to identify the independent predictor for PFS in patients with EGFR-mutant advanced lung adenocarcinoma and received EGFR-TKIs. A total of 131 lung adenocarcinoma patients with a median age of 58 years old were included in the final analysis. Patients with elevated level of DB and HDL-C showed a longer PFS, while high level of ALP and TBA indicated shorter PFS in response to EGFR-TKI treatment. The multivariate survival analyses revealed a significant association of prolonged PFS with increased DB, and decreased TBA. In conclusion, these findings suggest that DB and TBA were significant independent predictors of PFS in EGFR-TKI-treated patients with advanced lung adenocarcinoma.https://doi.org/10.1186/s12890-024-03367-1Total bile acidDirect bilirubinEpidermal growth factor receptor-tyrosine kinase inhibitorProgression-free survival |
| spellingShingle | Yuting Li Bicheng Wang Shihong Fei You Qin Predictive value of direct bilirubin and total bile acid in lung adenocarcinoma patients treated with EGFR-TKIs BMC Pulmonary Medicine Total bile acid Direct bilirubin Epidermal growth factor receptor-tyrosine kinase inhibitor Progression-free survival |
| title | Predictive value of direct bilirubin and total bile acid in lung adenocarcinoma patients treated with EGFR-TKIs |
| title_full | Predictive value of direct bilirubin and total bile acid in lung adenocarcinoma patients treated with EGFR-TKIs |
| title_fullStr | Predictive value of direct bilirubin and total bile acid in lung adenocarcinoma patients treated with EGFR-TKIs |
| title_full_unstemmed | Predictive value of direct bilirubin and total bile acid in lung adenocarcinoma patients treated with EGFR-TKIs |
| title_short | Predictive value of direct bilirubin and total bile acid in lung adenocarcinoma patients treated with EGFR-TKIs |
| title_sort | predictive value of direct bilirubin and total bile acid in lung adenocarcinoma patients treated with egfr tkis |
| topic | Total bile acid Direct bilirubin Epidermal growth factor receptor-tyrosine kinase inhibitor Progression-free survival |
| url | https://doi.org/10.1186/s12890-024-03367-1 |
| work_keys_str_mv | AT yutingli predictivevalueofdirectbilirubinandtotalbileacidinlungadenocarcinomapatientstreatedwithegfrtkis AT bichengwang predictivevalueofdirectbilirubinandtotalbileacidinlungadenocarcinomapatientstreatedwithegfrtkis AT shihongfei predictivevalueofdirectbilirubinandtotalbileacidinlungadenocarcinomapatientstreatedwithegfrtkis AT youqin predictivevalueofdirectbilirubinandtotalbileacidinlungadenocarcinomapatientstreatedwithegfrtkis |